Publications
Who's the fairest of them all? Which provincial pharmacare model would best protect Canadians against catastrophic drug costs? Healthcare quarterly (Toronto, Ont.)Healthc.Q.. 2004;7(4):suppl 13-9.
Whither seniors' pharmacare: lessons from (and for) Canada. Health affairs (Project Hope)Health.Aff.(Millwood). 2003;22(3):49-59.
On the validity of area-based income measures to proxy household income. BMC health services researchBMC Health Serv.Res.. 2008;8:79.
Twelve years' experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary tale. PLoS ONE. 2009;4(5).
Toward an understanding of high performance pharmaceutical policy systems: a ‘triple-A’ framework and example analysis. The Open Health and Policy Journal. 2009;2:1-9.
Toward a standard definition and measurement of persistence with drug therapy: Examples from research on statin and antihypertensive utilization. Clinical therapeuticsClin.Ther.. 2006;28(9):1411-24; discussion 1410.
Stitching the gaps in the Canadian public drug coverage patchwork?: a review of provincial pharmacare policy changes from 2000 to 2010. Health Policy. 2012;104(1):19-26.
Statistics and drug utilization: are prescribing rates really that high? CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienneCMAJ. 2001;165(11):1507-1508.
The sources and popularity of online drug information: an analysis of top search engine results and web page views. The Annals of PharmacotherapyAnn.Pharmacother.. 2011;45(3):350-356.
The sources and popularity of online drug information: an analysis of top search engine results and web page views. The Annals of pharmacotherapy. 2011;45(3):350-356.
The short-term impact of Ontario's generic pricing reforms. PloS onePLoS One. 2011;6(7):e23030.
The Short-Term Impact of Ontario's Generic Pricing Reforms. PloS one. 2011;6(7):e23030.
Sex, drugs and gender roles: mapping the use of sex and gender based analysis in pharmaceutical policy research. International journal for equity in healthInt.J.Equity Health.. 2010;9:26.
Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia. Health policy (Amsterdam, Netherlands)Health Policy. 2004;68(3):299-307.
Registration for public drug benefits across areas of differing ethnic composition in British Columbia, Canada. BMC health services researchBMC Health Serv.Res.. 2010;10:171.
The redistributive effect of the move from age-based to income-based prescription drug coverage in British Columbia, Canada. Health policy (Amsterdam, Netherlands)Health Policy. 2011;101(2):185-194.
Quantifying components of drug expenditure inflation: the British Columbia seniors' drug benefit plan. Health services researchHealth Serv.Res.. 2002;37(5):1243-1266.
Prescription Drug Use in Pregnancy: A Retrospective, Population-Based Study in British Columbia, Canada (2001–2006). Clinical Therapeutics. 2011.
Prescription drug use in pregnancy: a retrospective, population-based study in british columbia, Canada (2001-2006). Clinical Therapeutics. 2012;34(1):239-249.e2.
Prescription drug use during pregnancy in developed countries: a systematic review. Pharmacoepidemiology and Drug Safety. 2011;20(9):895-902.
Prescription drug expenditures and population demographics. Health services researchHealth Serv.Res.. 2006;41(2):411-428.
Predictive genetic tests and health system costs. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienneCMAJ. 2003;168(8):989-991.
Post-Romanow pharmacare: last-dollar first...first-dollar lost? HealthcarePapersHealthc.Pap.. 2004;4(3):10-20.
A population-based analysis of statin utilization in British Columbia. Clinical therapeuticsClin.Ther.. 2007;29(9):2107-2119.
Pharmaceutical use and outcomes: always a need for a sober second look. Healthcare policy = Politiques de santeHealthc.Policy.. 2007;3(1):10-22.
